G80.9 Insurance Policy Changes

ICD-10 G80.9 is officially defined as "Cerebral palsy, unspecified." code G80.9 is referenced in 8 tracked payer policy changes from Aetna and Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code G80.9 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Oct 28, 2026Medium impact
Motor Cortex Stimulation (CPB 0755, reviewed 2026-10-21)
Aetna's Clinical Policy Bulletin 0755 says Aetna considers motor cortex stimulation experimental, investigational, or unproven for the listed indications because its effectiveness has not been established. The listed indications include amyotrophic lateral sclerosis, autism spectrum disorder, cerebral palsy, chronic refractory pain, depression, dysphagia, Parkinson's disease, post-stroke aphasia, post-stroke hemiparesis, seizures, traumatic brain injury and obsessive compulsive disorder, and the bulletin says that list is not all-inclusive. The bulletin also lists CPT, HCPCS and ICD-10 codes that are not covered for the indications listed in the policy.
Aetna · Identified Oct 4, 2026Medium impact
Suit Therapy (CPB 0696, reviewed 2026-09-18)
Suit therapy, including the Adeli Suit, TheraTogs and other suit therapy devices, is considered experimental, investigational or unproven for cerebral palsy and other conditions, including gait rehabilitation following stroke. Dynamic movement orthoses are considered experimental, investigational or unproven for cerebral palsy, hemiparesis or hemiplegia, scoliosis and all other indications. The Dynamic Lycra Suit TLSO brace is considered experimental for cerebral palsy or scoliosis, and a TLSO is considered experimental for autism. The Benik vest or trunk support is considered experimental for individuals with low trunk tone and all other indications.
Aetna · Identified Aug 19, 2026Medium impact
Mechanical Stretching Devices for Contracture and Joint Stiffness (CPB 0405, reviewed 2026-06-30)
Aetna covers dynamic splinting devices for the knee, elbow, wrist, finger or toe when there are documented signs and symptoms of significant motion stiffness or loss and the splint is used as an adjunct to occupational or physical therapy at least 3 weeks after injury or surgery, or when the member has a documented history of motion loss in a joint and is in the acute post-operative period after a second or subsequent surgery. The policy also covers the dynamic adjustable ankle extension/flexion device (e.g., JAS Ankle) for contractures, the EZ Turnbuckle orthosis after open reduction internal fixation for radial head fracture, and continued mechanical stretching when documented improvement in range of motion is shown. Dynamic splinting for carpal tunnel syndrome, cerebral palsy, foot drop associated with neuromuscular diseases, multiple sclerosis, stroke and plantar fasciitis, JAS splints, PASS devices such as the ERMI flexionators and extensionators, SaeboMas, Medi-Dyne Prostretch, and mechanical stretching for skin graft contracture are considered experimental, investigational or unproven.
Aetna · Identified Aug 17, 2026Medium impact
Ambulatory Assist Devices: Canes, Crutches, and Walkers (CPB 0505, reviewed 2026-08-03)
Aetna considers canes, crutches, and walkers medically necessary durable medical equipment when the member has a mobility limitation that significantly impairs participation in one or more mobility-related activities of daily living (MRADL) in the home, the member can safely use the device, and the functional deficit can be sufficiently resolved by the device. Axillary, articulated, spring-assisted crutches, sit-and-stand walking assistant crutches, walkers with enclosed frames, walking belts, and standard strollers are not considered medically necessary, and enhancement accessories such as style, color, seat attachments, tray attachments, baskets, or cup holders are not covered. The AutoAmbulator, battery or electronic powered walkers such as the Sully Walker, the Upsee mobility device, and the wearable freezing of gait detection system are considered experimental, investigational, or unproven.
Aetna · Identified Aug 17, 2026Medium impact
Motor Cortex Stimulation (CPB 0755, reviewed 2026-02-24)
Aetna's Clinical Policy Bulletin 0755 on motor cortex stimulation, with a policy history last review of 10/21/2026, considers motor cortex stimulation experimental, investigational or unproven for many indications because its effectiveness has not been established. The list includes amyotrophic lateral sclerosis, autism spectrum disorder, cerebral palsy, chronic refractory pain (such as central pain syndromes, complex regional pain syndrome, phantom limb pain, thalamic pain and trigeminal neuropathic pain), depression, dysphagia, dystonia secondary to a focal basal ganglia lesion, movement disorders, obsessive compulsive disorder, Parkinson's disease, post-stroke aphasia, post-stroke hemiparesis, seizures, traumatic brain injury, and use of motor cortex stimulation during deep brain stimulator implantation. The policy lists CPT codes 61850, 61860, 61885, 61886, 64568, 95961, 95962 and 95970 as not covered for the indications it lists.
Aetna · Identified Aug 17, 2026Medium impact
Suit Therapy (CPB 0696, reviewed 2025-11-26)
Aetna considers suit therapy, including home use of suit therapy devices such as the Adeli Suit and TheraTogs, experimental, investigational, or unproven for members with cerebral palsy or other conditions, such as gait rehabilitation following stroke. Aetna also considers dynamic movement TLSO braces (Dynamic Lycra Suits) for cerebral palsy or scoliosis, Dynamic Movement Orthoses for cerebral palsy, hemiparesis or hemiplegia, scoliosis and all other indications, TLSO braces for autism, and the Benik vest for low trunk tone and all other indications experimental, investigational, or unproven.
Aetna · Identified Aug 14, 2026Medium impact
Gait Analysis and Electrodynogram (CPB 0263, reviewed 2026-04-16)
Aetna considers gait analysis, also called motion analysis, experimental, investigational or unproven for conditions that result in gait deviations and for all other indications. Dynamic electromyography, use of electrodynogram for all indications, and wearable devices for running gait analysis are listed in the same category. Aetna lists CPT 96000, 96001, 96002 and 96004 as not covered for the indications listed in the policy, along with ICD-10 codes for cerebral palsy, paraplegia and quadriplegia, abnormality of gait and mobility, and other lack of coordination, and the policy was last reviewed 04/16/2026 with its next review set for 03/11/2027.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Gait Analysis
Comprehensive gait analysis may be considered medically necessary as an aid in surgical planning in patients with gait disorders associated with cerebral palsy. Comprehensive gait analysis is considered investigational for other applications, including surgical planning for conditions other than gait disorders associated with cerebral palsy and postoperative evaluation of surgical outcomes and rehabilitation planning or evaluation for all conditions. Gait analysis that is not comprehensive is considered investigational.

Watch G80.9

Get one email when a payer policy names G80.9, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code G80.9?

There are 8 tracked policy changes affecting code G80.9, including updates from Aetna, Blue Cross & Blue Shield of Mississippi. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code G80.9?

Payers that have issued tracked updates for code G80.9 include: Aetna, Blue Cross & Blue Shield of Mississippi.

How do I get notified when code G80.9 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code G80.9. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code G80.9?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Motor Cortex Stimulation (CPB 0755, reviewed 2026-10-21)

Suit Therapy (CPB 0696, reviewed 2026-09-18)

Mechanical Stretching Devices for Contracture and Joint Stiffness (CPB 0405, reviewed 2026-06-30)

Ambulatory Assist Devices: Canes, Crutches, and Walkers (CPB 0505, reviewed 2026-08-03)

Motor Cortex Stimulation (CPB 0755, reviewed 2026-02-24)

Suit Therapy (CPB 0696, reviewed 2025-11-26)

Gait Analysis and Electrodynogram (CPB 0263, reviewed 2026-04-16)

Gait Analysis

What insurance policy changes affect code G80.9?

Which payers have updated policy for code G80.9?

How do I get notified when code G80.9 policy changes?

Why do payers change policies for code G80.9?